Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07832708
PHASE1
Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
The goal of this study is to evaluate the safety, tolerability, and pharmacokinetics of ABBV-1162 in healthy adults.
Official title: A Phase 1, Double-blind, Placebo-Controlled, First-in-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses ofABBV-1162 in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-11-02
Completion Date
2027-05
Last Updated
2026-09-22
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
ABBV-1162
Oral
DRUG
Placebo
Oral